Original Publication Date: 1 November, 2017
Publication / Source: Bioanalysis 9(21)
Authors: Sallese A and Zhu J
Metabolic syndrome: a global health concern
The rapid growth in obesity prevalence is causing an epidemic of health consequences leading to an astounding socioeconomic burden in the USA and abroad . A recent commission focused on predicting the prevalence and medical costs of cardiovascular disease (CVD) estimated that by 2035, 45% of the US population will have some form of CVD . In 2016 alone, CVD cost Americans 555 billion dollars and by 2035 that cost is estimated to reach 1.1 trillion . Metabolic syndrome (MetS) is defined as the presence of more than three cardiometabolic risk factors, which include central obesity, hypertension, elevated fasting glucose and dyslipidemia . MetS increases the risk for both CVD  and diabetes . In the USA, MetS affects up to 30–40% of the general population by age
Click here to view the full article in Bioanalysis.
Find out more about Jiangjiang (Chris) Zhu and his research in our interview series: ‘An author’s perspective‘.